Biome Australia Ltd: International Market Update and Health Canada approvals
Biome Australia Ltd: Quarterly Activities & Cashflow Report
Biome Australia Ltd: Non-Deal Investor Presentation April 2024
Biome Australia Ltd: Secondary Trading Notice
Biome Australia Ltd: Application for quotation of securities - BIO
Biome Australia Ltd: First Quarter of Positive Underlying Cash Flow
Biome Australia Ltd: Notification regarding unquoted securities - BIO
Biome Australia Ltd: Proposed issue of securities - BIO
Biome Australia Ltd: Issue of Options
Biome Australia Ltd: Biome Releases First Half FY2024 Results
Biome Australia Ltd: Appendix 4D & Half Yearly Report
Biome Australia Ltd: Secondary Trading Notice
Biome Australia Ltd: Application for quotation of securities - BIO
Biome Australia Ltd: Ceasing to be a substantial holder
Biome Australia Ltd: Quarterly Activities & Cashflow Report
Biome Australia Ltd: Biome to launch into UK and Ireland health retail
Biome Australia Ltd: FY24 Revenue Guidance Upgrade to $12.5M
Biome Australia Ltd: Biome Achieves Record Quarter and Half Year Sales
Biome Australia Ltd: Change in substantial holding
Biome Australia Ltd: Biome to launch cholesterol reducing probiotic
No Data